Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Intel (INTC) up 6% after Bloomberg reported the company is considering various scenarios, including a split of its product-design and manufacturing businesses, as well as which factory projects might potentially be scrapped
- Alibaba (BABA) up 4% after SCMP wrote China’s State Administration for Market Regulation, or SAMR, the nation’s market watchdog, praised Alibaba for its compliance with the antitrust authority as it put an official end to more than three years of regulatory scrutiny and closed out its antitrust review of the company
- Emergent BioSolutions (EBS) up 15% after announcing that the FDA has approved the supplemental Biologics License Application for the expansion of the indication for ACAM2000 to include prevention of mpox disease in individuals determined to be at high risk for mpox infection
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- Alnylam (ALNY) down 8% after announcing detailed results from the HELIOS-B Phase 3 study of vutrisiran
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BABA:
- Loop Capital not concerned about PDD results, sees positive path for Alibaba
- Could PDD Holdings’ Tough Road Ahead Be Bullish for Contrarians?
- Can JD.com Stock Break Free from Its Prolonged Underperformance?
- PDD Earnings: PDD’s Revenue Miss Triggers Sell-Off Despite Earnings Beat
- Powell says ‘time has come’ for Fed to cut: Morning Buzz